A citation-based method for searching scientific literature

Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson. Lancet Oncol 2017
Times Cited: 396



James Schuster, Rose K Lai, Lawrence D Recht, David A Reardon, Nina A Paleologos, Morris D Groves, Maciej M Mrugala, Randy Jensen, Joachim M Baehring, Andrew Sloan, Gary E Archer, Darell D Bigner, Scott Cruickshank, Jennifer A Green, Tibor Keler, Thomas A Davis, Amy B Heimberger, John H Sampson. Neuro Oncol 2015
Times Cited: 220




List of shared articles



Times cited

A review of glioblastoma immunotherapy.
Ravi Medikonda, Gavin Dunn, Maryam Rahman, Peter Fecci, Michael Lim. J Neurooncol 2021
29

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma.
Ketao Jin, Chunsen Mao, Lin Chen, Lude Wang, Yuyao Liu, Jianlie Yuan. Cancers (Basel) 2021
1

Updated Insights on EGFR Signaling Pathways in Glioma.
Alexandru Oprita, Stefania-Carina Baloi, Georgiana-Adeline Staicu, Oana Alexandru, Daniela Elise Tache, Suzana Danoiu, Elena Simona Micu, Ani-Simona Sevastre. Int J Mol Sci 2021
10

Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges.
Keenan Piper, Lisa DePledge, Michael Karsy, Charles Cobbs. Front Oncol 2021
2

Current Immunotherapies for Glioblastoma Multiforme.
Boyuan Huang, Xuesong Li, Yuntao Li, Jin Zhang, Zhitao Zong, Hongbo Zhang. Front Immunol 2021
6

Therapeutic Delivery to Central Nervous System.
Katherine E Kunigelis, Michael A Vogelbaum. Neurosurg Clin N Am 2021
2

Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan,[...]. Clin Transl Immunology 2021
1

Immunotherapy for Glioblastoma: Current Progress and Challenges.
Miranda W Yu, Daniela F Quail. Front Immunol 2021
2

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.
Julie Bolcaen, Shankari Nair, Cathryn H S Driver, Tebatso M G Boshomane, Thomas Ebenhan, Charlot Vandevoorde. Pharmaceuticals (Basel) 2021
0

Advances in Immunotherapy for Adult Glioblastoma.
Chirayu R Chokshi, Benjamin A Brakel, Nazanin Tatari, Neil Savage, Sabra K Salim, Chitra Venugopal, Sheila K Singh. Cancers (Basel) 2021
0

EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
Aline de Cristo Soares Alves, Vladimir Lavayen, Amanda de Fraga Dias, Franciele Aline Bruinsmann, Juliete Nathali Scholl, Rodrigo Cé, Fernanda Visioli, Ana Maria Oliveira Battastini, Silvia Stanisçuaski Guterres, Fabrício Figueiró,[...]. Nanomedicine (Lond) 2021
0

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Yogesh R Suryawanshi, Autumn J Schulze. Viruses 2021
2

Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review.
Muhammad Khan, Xianming Li, Maosheng Yan, Zihuang Li, Hongli Yang, Guixiang Liao. Int J Gen Med 2021
0

New Immunotherapeutic Approaches for Glioblastoma.
Gustavo Ignacio Vázquez Cervantes, Dinora F González Esquivel, Saúl Gómez-Manzo, Benjamín Pineda, Verónica Pérez de la Cruz. J Immunol Res 2021
0

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms.
Radhika Thokala, Zev A Binder, Yibo Yin, Logan Zhang, Jiasi Vicky Zhang, Daniel Y Zhang, Michael C Milone, Guo-Li Ming, Hongjun Song, Donald M O'Rourke. Front Oncol 2021
0

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma.
Mark Dapash, Brandyn Castro, David Hou, Catalina Lee-Chang. Cancers (Basel) 2021
1